NCT01910012 2020-10-01
PH 2 ADI-PEG 20 Acute Myeloid Leukemia
Polaris Group
Phase 2 Completed
Clinical Trials
5 trialsNCT01910025 2018-09-18
PH 2 ADI-PEG 20 Study in Non-Hodgkin's Lymphoma Subjects Who Have Failed Prior Systemic Therapy
Polaris Group
Phase 2 Completed
NCT02006030 2018-09-04
TACE
Polaris Group
Phase 2 Completed
NCT00450372 2017-02-08
Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery
University of Miami
Phase 2 Completed
NCT00056992 2015-03-25
Testing of ADI-PEG in Hepatocellular Carcinoma
FDA Office of Orphan Products Development
Phase 2 Completed